Daron Evans's Net Worth
$786 Thousand
Who is Daron Evans?
Daron Evans does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NEPHROS INC, and Nile Therapeutics, Inc..
SEC CIK
Daron Evans's CIK is 0001411726
Past Insider Trading and Trends
2017 was Daron Evans's most active year for acquiring shares with 17 total transactions. Daron Evans's most active month to acquire stocks was the month of November. 2021 was Daron Evans's most active year for disposing of shares, totalling 4 transactions. Daron Evans's most active month to dispose stocks was the month of April. 2018 saw Daron Evans paying a total of $47,550.00 for 445,715 shares, this is the most they've acquired in one year. In 2021 Daron Evans cashed out on 2,920 shares for a total of $1,884.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NEPHROS INC (NEPH) Snapshot price: $3.515
CEO Specialty Renal Products
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -3.81% | -698.00 |
$2.70 | -$1,884.60 | 17.62K |
May 27
| |||
Form 4
| +13.81% | 2.22K |
$2.70 | $5,999.40 | 18.31K |
May 24
| |||
Form 4
| +1.90% | 2.5K |
$6.65 | $16,625.00 | 134.22K |
Mar 12
| |||
Form 4
| +1.93% | 2.5K |
$8.44 | $21,109.00 | 131.72K |
Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +7.74% | 9.28K |
—
|
—
| 129.22K |
Dec 16
| |||
Form 4
| +0.84% | 1K |
$8.35 | $8,350.00 | 119.93K |
Nov 18
| |||
Form 4
| +1.71% | 2K |
$6.92 | $13,845.40 | 118.93K |
Aug 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 4
| +3.69% | 43.17K |
$0.60 | $25,760.69 | 1.21M |
Jun 14
| |||
Form 4
| +12.13% | 108.3K |
—
|
—
| 1M |
Dec 14
| |||
Form 4
| +72.73% | 40K |
$0.30 | $12,000.00 | 95K |
May 14
| |||
Form 4
| +75.36% | 79K |
$0.45 | $35,550.00 | 183.83K |
Apr 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +25.25% | 180K |
—
|
—
| 892.96K |
Dec 20
| |||
Form 4
| +4.33% | 29.58K |
$0.24 | $7,189.30 | 712.96K |
Sep 5 - Sep 6
| |||
Form 4
| +3.97% | 4K |
$0.25 | $1,000.00 | 104.83K |
Aug 22
| |||
Form 4
| +11.41% | 70K |
$0.26 | $18,200.00 | 683.38K |
Aug 11
| |||
Form 4
| +3.10% | 21.46K |
$0.26 | $5,579.86 | 714.21K |
Jun 9 - Jun 12
| |||
Form 4
| +5.18% | 30K |
$0.26 | $7,650.00 | 609.42K |
May 18 - May 19
| |||
Form 4
| +3.16% | 17.76K |
—
|
—
| 579.42K |
Mar 31
| |||
Form 4
|
∞
| 83.33K |
—
|
—
| 83.33K |
Mar 17
| |||
Form 4
| +61.12% | 213.07K |
—
|
—
| 561.66K |
Dec 23
| |||
Form 4
| +2.70% | 9.16K |
—
|
—
| 348.59K |
Dec 14
| |||
Form 4
| +1.21% | 4.07K |
$0.32 | $1,302.08 | 339.43K |
Dec 7
| |||
Form 4
| +3.27% | 10.62K |
$0.34 | $3,610.34 | 335.36K |
Dec 5
| |||
Form 4
| +14.66% | 41.53K |
$0.32 | $13,286.03 | 324.74K |
Nov 30 - Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
| +17.82% | 42.84K |
—
|
—
| 283.21K |
Dec 17
| |||
Form 4
| +41.59% | 70.61K |
—
|
—
| 240.37K |
Sep 9
| |||
Form 4
| +35.18% | 44.17K |
$0.57 | $25,338.00 | 169.76K |
Aug 27 - Aug 31
| |||
Form 4
| +69.52% | 51.5K |
$0.53 | $27,370.00 | 125.58K |
Aug 19 - Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
| +40.19% | 21.24K |
$0.60 | $12,743.40 | 74.08K |
Dec 18
| |||
Form 4
| +447.56% | 43.19K |
—
|
—
| 52.84K |
Nov 6
| |||
Form 4
| +28.68% | 2.15K |
$0.30 | $645.30 | 9.65K |
Mar 21 - Mar 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nile Therapeutics, Inc. (CAPR) Snapshot price: $3.9
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +95.04% | 12.5K |
—
|
—
| 25.65K |
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
| +38.75% | 3.95K |
—
|
—
| 14.15K |
Jul 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
| +130.95% | 11K |
$0.76 | $8,370.00 | 19.4K |
Mar 11 - Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
| +99.34% | 4.19K |
$0.98 | $3,480.20 | 8.4K |
Dec 12
| |||
Form 4
| +953.50% | 3.81K |
$0.68 | $2,869.56 | 4.21K |
Dec 11
| |||
Form 4
|
∞
| 800 |
$4.55 | $3,640.00 | 800 |
Apr 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rezolute, Inc. (RZLT) No price found
CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 40K |
$4.04 | $161,568.00 | 40K |
Jun 14
| |||
Form 4
| +0.37% | 451 |
$3.50 | $1,578.50 | 121.35K |
May 29
| |||
Form 4
| +30.00% | 3K |
$3.22 | $9,667.96 | 13K |
May 23 - May 24
| |||
Form 4
|
∞
| 20K |
$1.69 | $33,830.00 | 20K |
Mar 15
| |||
Form 4
| +70.52% | 50K |
$1.93 | $96,345.00 | 120.9K |
Mar 8
| |||
Form 4
| +175.52% | 50.9K |
$1.35 | $66,741.34 | 79.9K |
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||